Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk
--Data presented at the American College of Cardiology Annual Scientific Session show…
137th Canton Fair Promotes Innovation and Trade in Hong Kong and Macao, Bringing Regional Economy to New Heights
GUANGZHOU, China, March 28, 2025 /PRNewswire/ -- The 137th Canton Fair, set…
Woodside to Divest Greater Angostura Assets to Perenco
HOUSTON--(BUSINESS WIRE)--Woodside has entered into an agreement with Perenco to divest its…
Rapid7 Appoints Three New Board Members
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a…
Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis
Significantly more patients treated with Sotyktu achieved ACR and PASI response rates…
Empowering Women in Crypto: BitMarts Commitment Beyond International Womens Day
Mahe, Seychelles , March 07, 2025 (GLOBE NEWSWIRE) -- Women are making…
Study finds that 88 per cent of Paris region residents engaged with the Games
04 March 2025 - Nearly nine in ten residents of the greater Paris…
INDIAWOOD 2025: 25 Years of Driving Innovation in Woodworking & Furniture Manufacturing
NEW DELHI, March 4, 2025 /PRNewswire/ -- Marking a quarter-century of industry…
Aclarion Announces First Commercial Agreement with Scripps Health
Agreement expands access to Nociscan technology for leading spine physicians and more…
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment,…